英文名稱(chēng) | Sibeprenlimab (Synonyms: VIS649) |
---|---|
中文名稱(chēng) | 西貝瑞單抗 |
CAS號(hào) | 2382896-07-1 |
儲(chǔ)存條件 | store at -80°C | Shipping with blue ice. |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 | |
---|---|---|---|---|---|
暫無(wú)牌價(jià)信息,您可以發(fā)送詢(xún)價(jià),我們會(huì)盡快給你回復(fù)。 |
英文名稱(chēng) | Sibeprenlimab (Synonyms: VIS649) |
---|---|
中文名稱(chēng) | 西貝瑞單抗 |
CAS號(hào) | 2382896-07-1 |
儲(chǔ)存條件 | store at -80°C | Shipping with blue ice. |
Sibeprenlimab (VIS649), a humanized IgG2 monoclonal antibody, neutralizes APRIL, a key factor in IgA nephropathy (IgAN) pathogenesis. It effectively reduces pathogenic IgA and IgM while preserving vaccine responses to SARS-CoV-2 mRNA-based vaccines. Clinical trials demonstrate that sibeprenlimab decreases UPCR and stabilizes GFR, positioning it as a promising treatment for IgAN.
Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
PMID: 37966286 DOI: 10.1056/NEJMoa2306263
PMID: 37959392 PMCID: PMC10650434 DOI: 10.3390/jcm12216927
PMID: 35570983 PMCID: PMC9091613 DOI: 10.1016/j.ekir.2022.01.1073